tiprankstipranks
Trending News
More News >
Merck & Company (DE:6MK)
XETRA:6MK
Advertisement

Merck & Company (6MK) Similar Stocks

Compare
68 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Merck & Company
€72.20
$179.02B
10.58
-19.32%
4 Buy
7 Hold
0 Sell
Moderate Buy
AstraZeneca
$81.72
$251.51B
30.44
16.79%
5 Buy
0 Hold
0 Sell
Strong Buy
Gilead Sciences
$122.05
$148.64B
18.57
39.31%
18 Buy
4 Hold
0 Sell
Strong Buy
Novartis
$123.86
$234.73B
16.76
15.47%
0 Buy
2 Hold
1 Sell
Moderate Sell
Pfizer
$24.66
$140.21B
13.12
-5.70%
4 Buy
11 Hold
1 Sell
Hold
Sanofi
$49.73
$122.00B
12.44
-2.28%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:6MK
Merck & Company
72.20
-17.29
-19.32%
AZN
AstraZeneca
81.72
16.81
25.90%
GILD
Gilead Sciences
122.05
34.44
39.31%
NVS
Novartis
123.86
17.70
16.67%
PFE
Pfizer
24.66
-1.49
-5.70%
SNY
Sanofi
50.05
-1.17
-2.28%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis